Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 18.12M | $ 42.05M | $ 60.92M | $ 47.60M | $ 42.97M |
Total Assets | $ 245.62M | $ 275.14M | $ 254.53M | $ 228.10M | $ 215.35M |
Total Debt | $ 79.49M | $ 69.21M | $ 58.54M | $ 59.82M | $ 59.27M |
Net Debt | $ 61.37M | $ 27.15M | $ -2.38M | $ 12.22M | $ 16.30M |
Total Liabilities | $ 109.80M | $ 102.27M | $ 82.82M | $ 91.50M | $ 85.47M |
Stockholders Equity | $ 130.46M | $ 137.34M | $ 135.47M | $ 99.44M | $ 94.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |